Parallel Advisors’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $38.2K | Buy |
|
|||||
|
2025
Q2 | $26.2K | Buy |
|
|||||
|
2025
Q1 | $17.2K | Buy |
|
|||||
|
2024
Q4 | $17.3K | Hold |
|
|||||
|
2024
Q3 | $20.7K | Sell |
|
|||||
|
2024
Q2 | $45.3K | Buy |
|
|||||
|
2024
Q1 | $50.6K | Buy |
|
|||||
|
2023
Q4 | $22K | Buy |
|
|||||
|
2023
Q3 | $9.67K | Buy |
|
|||||
|
2023
Q2 | $10.8K | Hold |
|
|||||
|
2023
Q1 | $8.73K | Sell |
|
|||||
|
2022
Q4 | $9.76K | Sell |
|
|||||
|
2022
Q3 | $21K | Sell |
|
|||||
|
2022
Q2 | $19K | Buy |
|
|||||
|
2022
Q1 | $19K | Sell |
|
|||||
|
2021
Q4 | $31K | Buy |
|
|||||
|
2021
Q3 | $37K | Sell |
|
|||||
|
2021
Q2 | $70K | Buy |
|
|||||
|
2021
Q1 | $38K | Buy |
|
|||||
|
2020
Q4 | $38K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $23K | Buy |
|
|||||
|
2019
Q4 | $22K | Hold |
|
|||||
|
2019
Q3 | $15K | Hold |
|
|||||
|
2019
Q2 | $17K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $11K | Buy |
|